Altogether, these studies are consistent with our present findings in melanoma, suggesting that Smad3 may play a more prominent role in the mediation of the TGFβ tumor-suppressive effects compared to Smad2 in various models of solid tumors. The gene discussed is SMAD2; the disease is melanoma.